NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTION
BAXTER CORPORATION
Quick answers
Is there a shortage of NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTION in Canada?
No. There is no current shortage of NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTION 0.032MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
NOREPINEPHRINE BITARTRATE INJECTION USP
SANDOZ CANADA INCORPORATED
LEVOPHED LIQ IV 1.0MG/ML
SANOFI CANADA, INC.
NOREPINEPHRINE BITARTRATE INJECTION, USP
STERIMAX INC
NOREPINEPHRINE BITARTRATE INJECTION
AS KALCEKS
NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTION
BAXTER CORPORATION
DIN
02501449
Strength
0.032MG
Dosage Form
Solution
Route
Intravenous
Active Ingredient
NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE)
See all NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from BAXTER CORPORATION
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 00438014
DIN 00786292
DIN 00438049
DIN 00786209
DIN 00437999
DIN 00786217
DIN 00438030
DIN 00438022
DIN 00438006
DIN 00828602
900MG · DIN 00060208
900MG · DIN 00786160